scholarly article | Q13442814 |
P356 | DOI | 10.1152/JAPPL.1989.67.6.2542 |
P8608 | Fatcat ID | release_iriiks3qcbaclm5vxx7lrt3gme |
P953 | full work available at URL | http://jap.physiology.org/cgi/content/abstract/67/6/2542 |
P2880 | NIOSHTIC-2 ID | 00193658 |
P698 | PubMed publication ID | 2558103 |
P2093 | author name string | C Hopkins | |
A M Sciuto | |||
G H Gurtner | |||
J R Michael | |||
T P Kennedy | |||
E Tolley | |||
J R Hoidal | |||
D Hasty | |||
G K Bysani | |||
R Lazar | |||
P6195 | funding scheme | grant | Q230788 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary edema | Q857667 |
list of highly toxic gases | Q2263216 | ||
respiratory disease | Q3286546 | ||
phosgene | Q189090 | ||
lung disease | Q3392853 | ||
occupational lung disease | Q7075805 | ||
P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
P304 | page(s) | 2542-52 | |
P12526 | performing organization | University of Tennessee Health Science Center | Q7896420 |
P577 | publication date | 1989-12-01 | |
P1433 | published in | Journal of Applied Physiology | Q1091719 |
P859 | sponsor | National Institute for Occupational Safety and Health | Q60346 |
P1476 | title | Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene | |
P478 | volume | 67 |
Q44018762 | Acute changes in lung histopathology and bronchoalveolar lavage parameters in mice exposed to the choking agent gas phosgene |
Q35938701 | Acute lung injury after phosgene inhalation |
Q44689954 | Adenosine modulates vascular resistance and fluid filtration in isolated rat lungs |
Q52514509 | Adenosine protects ultrastructure of isolated rat lungs against fat emulsion injury. |
Q46474681 | Attenuation of LPS-induced neutrophil thromboxane B2 release and chemiluminescence |
Q46164473 | Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence |
Q36484322 | Clinical management of casualties exposed to lung damaging agents: a critical review |
Q38420382 | Conceptual approaches for treatment of phosgene inhalation-induced lung injury. |
Q36015327 | Defining the phosphodiesterase superfamily members in rat brain microvessels |
Q74219229 | Dibutylyl cyclic adenosine monophosphate attenuates damage in the ultrastructure of endothelial cells in 15-hour cold preserved rat lungs |
Q73807558 | Dibutyryl cyclic adenosine monophosphate attenuates lung injury caused by cold preservation and ischemia-reperfusion |
Q43186150 | Early treatment with nebulised salbutamol worsens physiological measures and does not improve survival following phosgene induced acute lung injury |
Q31948108 | Effect of dietary treatment with n-propyl gallate or vitamin E on the survival of mice exposed to phosgene |
Q77101725 | Effect of preischemic catecholamine treatment on ischemia-reperfusion injury of the myocardium: subtype, dose, and temperature dependency |
Q39327987 | Evaluation of an in vitro screening model to assess phosgene inhalation injury |
Q34263355 | Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron |
Q74217148 | In vitro adduct formation of phosgene with albumin and hemoglobin in human blood |
Q78242231 | Is the use of catecholamine before ischemic arrest safe? Effect of catecholamine on rat heart ischemia/reperfusion injury |
Q37789760 | Management of phosgene-induced acute lung injury |
Q28369563 | Mechanisms underlying enhanced responses of J receptors of cats to excitants in pulmonary oedema |
Q34695957 | Microbiological, biological, and chemical weapons of warfare and terrorism |
Q67690110 | Norepinephrine and iloprost improve barrier function of human endothelial cell monolayers: role of cAMP |
Q36738993 | Phosgene effects on F-actin organization and concentration in cells cultured from sheep and rat lung |
Q30407772 | Phosgene exposure: a case of accidental industrial exposure |
Q32066461 | Phosgene exposure: mechanisms of injury and treatment strategies |
Q73458185 | Postexposure treatment with aminophylline protects against phosgene-induced acute lung injury |
Q46821949 | Posttreatment with eicosatetraynoic acid decreases lung edema in guinea pigs exposed to phosgene: the role of leukotrienes |
Q71596856 | Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP |
Q43981329 | Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4). |
Q40304072 | Role of phosphodiesterases in the regulation of endothelial permeability in vitro |
Q40444772 | Role of the lung in accumulation and metabolism of xenobiotic compounds--implications for chemically induced toxicity |
Q33712167 | The role of oxidative stress in diseases caused by mineral dusts and fibres: current status and future of prophylaxis and treatment |
Q35809694 | Therapeutic treatments of phosgene-induced lung injury |
Q39468819 | Toxic effects following phosgene exposure of human epithelial lung cells in vitro using a CULTEX® system |
Q46865431 | Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance |
Q43505285 | beta-adrenergic stimulation restores rat lung ability to clear edema in ventilator-associated lung injury. |
Search more.